Actuate Therapeutics Ownership | Who Owns Actuate Therapeutics?

Actuate Therapeutics Ownership Summary

Actuate Therapeutics is owned by 60.36% institutional investors, 16.14% insiders, and 23.49% retail investors. Bios capital management, lp is the largest institutional shareholder, holding 51.15% of ACTU shares.

ACTU Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Actuate Therapeutics	60.36%	16.14%	23.49%
Sector	Healthcare Stocks	232.20%	10.74%	-142.94%
Industry	Biotech Stocks	382.11%	10.55%	-292.66%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Bios capital management, lp	10.05M	51.15%	$67.23M
Vanguard group	529.11K	2.47%	$3.24M
Blackrock funding, inc. /de	432.04K	2.02%	$2.64M
Voss capital	286.14K	1.46%	$1.75M
Geode capital management	207.74K	0.97%	$1.27M
Texas capital bank wealth management services	94.59K	0.44%	$578.90K
Northern trust	85.45K	0.43%	$571.69K
State street	49.90K	0.25%	$333.80K
Rock creek group, lp	21.76K	0.10%	$133.16K
Sfmg	20.00K	0.09%	$122.40K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Bios capital management, lp	10.05M	75.62%	$67.23M
Voss capital	286.14K	0.12%	$1.75M
Abs direct equity fund	6.60K	0.05%	$40.37K
Texas capital bank wealth management services	94.59K	0.03%	$578.90K
Rock creek group, lp	21.76K	0.01%	$133.16K
Gleason group	19.03K	0.01%	$116.45K
Sfmg	20.00K	0.01%	$122.40K
Global retirement partners	6.25K	0.00%	$38.25K
Northwestern mutual wealth management	10.02K	0.00%	$567.38K
Tower research capital llc (trc)	1.64K	0.00%	$10.99K

Top Buyers

Holder	Shares	% Assets	Change
Vanguard group	529.11K	-	213.10K
Blackrock funding, inc. /de	432.04K	-	149.97K
Texas capital bank wealth management services	94.59K	0.03%	94.59K
Bios capital management, lp	10.05M	75.62%	84.92K
Geode capital management	207.74K	0.00%	62.33K

Top Sellers

Holder	Shares	% Assets	Change
Sigma planning	-	-	-23.68K
Mercer global advisors inc /adv	-	-	-16.34K
Marshall wace, llp	-	-	-16.11K
Kg&l capital management	-	-	-12.00K
Chicago partners investment group	-	-	-10.37K

New Positions

Holder	Shares	% Assets	Change	Value
Texas capital bank wealth management services	94.59K	0.03%	94.59K	$578.90K
Rock creek group, lp	21.76K	0.01%	21.76K	$133.16K
Jane street group	16.63K	-	16.63K	$101.75K
Bank of new york mellon	12.56K	-	12.56K	$76.90K
Abs direct equity fund	6.60K	0.05%	6.60K	$40.37K

Sold Out

Holder	Change
Srs capital advisors	-60.00
Pnc financial services group	-384.00
Prosight management, lp	-885.00
Wealthspire advisors	-5.00K
Tang capital management	-5.24K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2025	33	-21.43%	12,914,920	7.39%	60	1.61%	23	4.55%	5	-58.33%
Sep 30, 2025	42	10.53%	11,416,022	1.77%	58	1.76%	21	-36.36%	12	500.00%
Jun 30, 2025	37	48.00%	11,216,230	7.83%	57	2.02%	32	68.42%	2	100.00%
Mar 31, 2025	25	31.58%	10,401,592	2.82%	53	0.37%	19	35.71%	1	-50.00%
Dec 31, 2024	19	90.00%	10,116,136	2547.05%	120	960.02%	14	40.00%	2	-

Recent Insider Transactions

Date	Name	Activity	Value
Jan 05, 2026	THOMSON TODD S	Sell	$1.62M
Jun 27, 2025	Bios Equity COF, LP	Buy	$500.00K
Jun 27, 2025	Bios Equity COF, LP	Buy	$500.00K
Jun 27, 2025	Kreis Leslie W.	Buy	$500.00K
Jun 27, 2025	Kreis Leslie W.	Buy	$500.00K

Insider Transactions Trends

Date	Buy	Sell
2026 Q1	-	1
2025 Q2	6	-
2014 Q2	-	-
2013 Q2	-	-
2012 Q4	-	-

ACTU Ownership FAQ

Who Owns Actuate Therapeutics?

Actuate Therapeutics shareholders are primarily institutional investors at 60.36%, followed by 16.14% insiders and 23.50% retail investors. The average institutional ownership in Actuate Therapeutics's industry, Biotech Stocks , is 382.11%, which Actuate Therapeutics falls below.

Who owns the most shares of Actuate Therapeutics?

Actuate Therapeutics’s largest shareholders are Bios capital management, lp (10.05M shares, 51.15%), Vanguard group (529.11K shares, 2.47%), and Blackrock funding, inc. /de (432.04K shares, 2.02%). Together, they hold 55.65% of Actuate Therapeutics’s total shares outstanding.

Does Blackrock own Actuate Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Actuate Therapeutics.

Who is Actuate Therapeutics’s biggest shareholder by percentage of total assets invested?

Bios capital management, lp is Actuate Therapeutics’s biggest shareholder by percentage of total assets invested, with 75.62% of its assets in 10.05M Actuate Therapeutics shares, valued at 67.23M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools